For help on how to get the results you want, see our search tips.
62 results
Medicine
Referrals Remove Referrals filter
Referral status
European Commission final decision Remove European Commission final decision filter
Under evaluation Remove Under evaluation filter
Referral type
Article 30 referrals Remove Article 30 referrals filter
Article 6(13) referrals (prior to January 2010) Remove Article 6(13) referrals (prior to January 2010) filter
Article 31 referrals Remove Article 31 referrals filter
Referral safety status
Yes Remove Yes filter
-
List item
Referral: Cisapride
cisapride, Article 31 referrals
Status: European Commission final decision, opinion/position date: 13/12/2001, EC decision date: 30/05/2002, Last updated: 29/10/2002 -
List item
Referral: Vigabatrin
vigabatrin, Article 31 referrals
Status: European Commission final decision, opinion/position date: 20/05/1999, EC decision date: 05/10/1999, Last updated: 12/10/1998 -
List item
Referral: Chlormezanone
chlormezanone, Article 31 referrals
Status: European Commission final decision, opinion/position date: 23/01/1997, EC decision date: 27/08/1997, Last updated: 22/09/1997 -
List item
Referral: Anorectics
phentermine, amfepramome, clobenzorex, dexfenfluramine, fenbutrazate, fenfluramine, fenproporex, mazindol, mefenorex, norpseudoephedrine, phenmetrazine, phendimetrazine, propylhexedrine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 16/02/1996, EC decision date: 09/12/1996, Last updated: 10/12/1996 -
List item
Referral: Trimetazidine
trimetazidine, associated names: Vastarel, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/06/2012, EC decision date: 03/09/2012, Last updated: 17/10/2012 -
List item
Referral: Terpenic derivatives
camphor, cineole, niaouli, wild thyme, terpineol, terpine, citral, menthol, essential oils of pine needle, eucalyptus and turpentine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 17/11/2011, EC decision date: 20/01/2012, Last updated: 13/04/2012 -
List item
Referral: Modified-released oral opioids
hydromorphone, morphine, oxycodone, Article 31 referrals
Status: European Commission final decision, opinion/position date: 18/11/2010, EC decision date: 20/04/2011, Last updated: 06/06/2011 -
List item
Referral: Zagam
sparfloxacin, Article 31 referrals
Status: European Commission final decision, opinion/position date: 19/12/1995, Last updated: 06/05/1996 -
List item
Referral: Orlistat
orlistat, Article 31 referrals
Status: European Commission final decision, opinion/position date: 16/02/2012, EC decision date: 24/04/2012, Last updated: 21/12/2012 -
List item
Referral: Dexrazoxane
dexrazoxane, associated names: Cardioxane, Cyrdanax, Dexrazoxane Cyathus, Enaxozar, Procard, Article 31 referrals
Status: European Commission final decision, opinion/position date: 23/06/2011, EC decision date: 13/09/2011, Last updated: 16/01/2012 -
List item
Referral: Octagam
human normal immunoglobulin, Article 31 referrals
Status: European Commission final decision, opinion/position date: 14/04/2011, EC decision date: 30/05/2011, Last updated: 26/04/2011 -
List item
Referral: Tolperisone
tolperisone, Article 31 referrals
Status: European Commission final decision, opinion/position date: 18/10/2012, EC decision date: 21/01/2013, Last updated: 02/04/2013 -
List item
Referral: Paroxetine
paroxetine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 09/12/2004, EC decision date: 29/03/2005, Last updated: 22/11/2005 -
List item
Referral: Linoladiol N and Linoladiol HN
estradiol, Article 31 referrals
Status: European Commission final decision, opinion/position date: 25/04/2014, EC decision date: 19/08/2014, Last updated: 11/09/2014 -
List item
Referral: Serotonin-specific reuptake inhibitors and serotonin-noradrenaline reuptake inhibitors
atomoxetine, citalopram, escitalopram, fluoxetine, fluvoxamine, mianserine, milnacipran, mirtazapine, paroxetine, reboxetine, sertraline, venlafaxine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/04/2005, EC decision date: 19/08/2005, Last updated: 03/11/2005 -
List item
Referral: Elidel
pimecrolimus, Article 31 referrals
Status: European Commission final decision, opinion/position date: 23/03/2006, Last updated: 29/08/2006 -
List item
Referral: Dextropropoxyphene
dextropropoxyphene, Article 31 referrals
Status: European Commission final decision, opinion/position date: 22/10/2009, EC decision date: 14/06/2010, Last updated: 07/04/2011 -
List item
Referral: Bisphosphonates
alendronic acid, clodronic acid, etidronic acid, ibandronic acid, neridronic acid, pamidronic acid, risedronic acid, tiludronic acid, zoledronic acid, associated names: Actonel, Aredia, Bonefos, Didronel, Fosamax, Nerixia, Skelid, Article 31 referrals
Status: European Commission final decision, opinion/position date: 14/04/2011, EC decision date: 13/07/2011, Last updated: 28/10/2011 -
List item
Referral: Terfenadine
terfenadine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 20/11/1997, EC decision date: 22/09/1998, Last updated: 22/01/1998 -
List item
Referral: Naftidrofuryl
naftidrofuryl, Article 31 referrals
Status: European Commission final decision, opinion/position date: 19/10/1995, EC decision date: 26/06/1996, Last updated: 26/06/1996 -
List item
Referral: Monovalent and multivalent measles, mumps, rubella and / or varicella vaccines
monovalent and multivalent measles, mumps, rubella and varicella vaccines (live), associated names: Amunovax, Priorix, Priorix Tetra, Provarivax, R.O.R. Vax, Rouvax, Trivivac, Varilrix, Varivax, Article 31 referrals
Status: European Commission final decision, opinion/position date: 13/12/2012, EC decision date: 27/06/2013, Last updated: 12/03/2014 -
List item
Referral: Loratadine and pseudoephedrine
loratadine, pseudoephedrine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/11/2003, EC decision date: 28/04/2004, Last updated: 14/07/2004 -
List item
Referral: Calcitonin
calcitonin, Article 31 referrals
Status: European Commission final decision, opinion/position date: 19/07/2012, EC decision date: 13/02/2013, Last updated: 19/07/2013 -
List item
Referral: Nimesulide
nimesulide, Article 31 referrals
Status: European Commission final decision, opinion/position date: 18/12/2003, EC decision date: 26/04/2004, Last updated: 13/05/2004 -
List item
Referral: Etoricoxib
etoricoxib, Article 31 referrals
Status: European Commission final decision, opinion/position date: 26/06/2008, Last updated: 21/11/2008